Dr Michael Zulyniak
- Position: Lecturer of Obesity
- Areas of expertise: nutrition; molecular epidemiology; genomics, metabolomics, systematic reviews & meta-analyses, high-risk populations, obesity, dysglycemia, and diabetes.
- Email: M.A.Zulyniak@leeds.ac.uk
- Phone: +44(0)113 343 0685
- Location: 7.66 EC Stoner
- Website: Twitter | Researchgate | ORCID
My primary research aim is to identify the underlying determinants of disease determinants in high-risk minority ethnic groups. This cannot be accomplished using a single method and is, therefore, dependent on several disciplines and methodologies. To date, using a combination of cohort and clincial trial data, my work suggests that populations that differ in age, ethcnity, or body weight metabolise foods differently and that this difference is associated with future disease risk.
My current research focusses on undertanding the mechanisms by which these high-risk metabolic differences influence disease risk and identifying the metabolic differneces that are most responsive to disease prevention and management. To acccomplish this requires an a collaborative and cross-disciplinary approach that harnesses and networks the strengths of various types of biological and environmental data – i.e., nutritional, genomic, metabolomic, molecular, and clinical data. Doing so allows us to identify the distinct and combined impacts of each system on health and disease, and can even point us towards the ideal targets to lower disese risk.This work is reliant on observational data from large cohorts, such as the UK Biobank and Born in Bradford, and expertise in nutrtional epidemilogy, molecular epidemiology, and statistics.
- Lead Academic Tutor
- Module Leader
- The role of nutrition on disease prevention and development, particulalrly in high-risk groups;
- The interaction between the genes and nutrition and their role in health and disease;
- Identifying and understanding gene*nutrient interactions at the population level (ethnicity, sex, age, etc.)
- Summary and evaluaiton of research evidence (through systematic reviews and meta-analyses).
Principle Investigator (or co-Principle Investigator)
- Wellcome Trust. Early maternal predictors of infant birth weight and adult cardiometabolic risk in South Asians. £98,037
- N8 AgriFood. Greenhouse gas and Dietary choices Open source Toolkit (GDOT) Hack-Nights. £8,451
- Hamilton Health Sciences. New Investigator Fund. Trimethylamine-N-Oxide (TMAO) and Myocardial Infarction in Multi-Ethnic Canadian and Global Populations $49,977 (CAD)
- CIHR. Randomized Controlled Trials: Mentoring Plan. $140,000 (CAD)
- CIHR. A culturally-tailored personalizeD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus: a randomized trial (DESI-GDM). $300,000 (CAD)
- WHO. Systematic review and meta-analysis on the effects of dietary PUFA on cardiometabolic, atopic, and neurocognitive development in children, pregnant women, and adults. $31,084 (CAD)
- BSc. University of Saskatchewan (Canada), Kinesiology
- MSc. University of Aberdeen (UK) Molecular Exercise Physiology
- PhD. University of Guelph (Canada), Human Health and Nutritional Sciences
- Research Fellowship. McMaster University (Canada). Department of Medicine.
- Association for the Study of Obesity (Member)
- The Nutrition Society (Member)
- Lifestyle Genomics (Journal, Associate Editor)
I lead an undergradate module which covers molecular and cellular biology, nutrition, and metabolism and deliver guest lectures on the topics of nutrition, genomics, and obesity. I also mentor 2nd year undergrauate students perparing literature reviews and final year undergraduate and MSc research projects.
Research groups and institutes
- Nutrition and Public Health
- Nutritional Epidemiology
- Obesity, Cancer and Metabolic Disease
- Human Nutrition and Lifestyle Intervention
Current postgraduate researchers
<li><a href="//phd.leeds.ac.uk/project/143-the-role-of-genetics-in-the-regulation-of-metabolism-and-cardiometabolic-diseases-and-cancer">The role of genetics in the regulation of metabolism and cardiometabolic diseases and cancer</a></li>